Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

MedTech Acquisition Corporation MTAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Il y a eu 33 transactions d'initiés récentes enregistrées pour MedTech Acquisition Corporation (MTAC), dont 14 achats et 14 ventes. Le total des achats d'initiés s'élève à $9.01M et le total des ventes d'initiés à $5.27M.

Les initiés notables ayant une activité récente comprennent Devlin Jodi, Szela Mary T, Murphy Sean. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — MTAC

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2023-08-30 Devlin Jodi President, Therapeutics Attribution de RSU 195,000 $6.70 $1.31M 195,000
2023-08-28 Devlin Jodi Officer Inconnu - - - -
2023-08-14 Szela Mary T CEO and President Attribution de RSU 172,500 $11.51 $1.99M 172,500
2023-08-11 Murphy Sean Chief Financial Officer Attribution de RSU 62,500 $12.00 $750K 62,500
2023-08-11 Cox Bryan F. Chief Scientific & Manufact. Attribution de RSU 40,000 $12.00 $480K 40,000
2023-08-11 Stevens Jennifer Chief Regulatory Officer Attribution de RSU 40,000 $12.00 $480K 40,000
2023-08-11 Marshak Richard Sr.vp, Corp. Dev. & Strategy Attribution de RSU 40,000 $12.00 $480K 40,000
2023-08-11 Katz Steven C Chief Medical Officer Attribution de RSU 62,500 $12.00 $750K 62,500
2023-08-10 Hicks Kerry R Director Cession 4,943 $2.43 $12.01K -
2023-08-10 Hicks Kerry R Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Matlin David J Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Wahlstrom Mats 10 Percent Owner Inconnu 50,000 $10.00 $500K -
2023-08-10 Wahlstrom Mats 10 Percent Owner Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Von Eschenbach Andrew C. Director Inconnu - - - -
2023-08-10 Von Eschenbach Andrew C. Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Murphy Sean Chief Financial Officer Cession 31,287 $10.30 $322.26K -
2023-08-10 Alecxih James President, Device Technology Cession 94,754 $10.30 $975.97K -
2023-08-10 Cox Bryan F. Chief Scientific & Manufact. Cession 8,391 $10.30 $86.43K -
2023-08-10 Martin George Kelly Director Inconnu - - - -
2023-08-10 Martin George Kelly Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Stevens Jennifer Chief Regulatory Officer Cession 8,391 $10.30 $86.43K -
2023-08-10 Marshak Richard Sr.vp, Corp. Dev. & Strategy Cession 8,391 $10.30 $86.43K -
2023-08-10 Singhal Anil K. Director Cession 12,359 $2.43 $30.03K -
2023-08-10 Singhal Anil K. Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Desai Arjun Jj Director Cession - - - 203,127
2023-08-10 Desai Arjun Jj Director Attribution de RSU 35,000 $11.34 $396.9K 35,000
2023-08-10 Katz Steven C Chief Medical Officer Cession 31,040 $10.30 $319.71K -
2023-08-10 Frankenius Equity Ab 10 Percent Owner Cession 230,000 $10.00 $2.3M -
2023-08-10 Szela Mary T CEO and President Cession 58,409 $10.30 $601.61K -
2023-06-26 Medtech Acquisition Sponsor Llc 10 Percent Owner Conversion (Vente) 6,249,999 - - 1
2023-06-12 Magnetar Financial Llc 10 Percent Owner Autre (Vente) 42,567 $10.49 $446.36K -
2022-12-12 Magnetar Financial Llc Director Inconnu - - - 21,780
2020-12-17 Desai Arjun Jj Director Cession 246,667 - - -
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message